By Reuters Staff
2 Min Read
DUBAI (Reuters) - Abu Dhabi’s Etihad Airways is still targeting a return to profit in 2023, despite a more than doubling in core operating losses last year, after accelerating its restructuring during the pandemic.
FILE PHOTO: A model Etihad Airways plane is seen on stage in New York, U.S. November 13, 2014. REUTERS/Lucas Jackson
The state carrier, which started a five-year turnaround plan three years ago, said on Thursday it had shed 33% of its workforce, reducing it to 13,587.
Etihad, which grounded most of its fleet between March and June, posted a core operating loss of $1.7 billion for 2020.
Abu Dhabi's Etihad Airways said on Wednesday the majority of its pilots and cabin crew had received two of the required doses of a coronavirus vaccine.
UPDATE 1-Abu Dhabi s Etihad says majority of pilots, crew taken both vaccine doses Reuters 2/10/2021
(Writes through, adds additional Etihad comment)
DUBAI, Feb 10 (Reuters) - Abu Dhabi s Etihad Airways said on Wednesday the majority of its pilots and cabin crew had received two of the required doses of a coronavirus vaccine.
The airline earlier said flights were only being operated by pilots and cabin crew who had been vaccinated, which a spokeswoman later said meant had received at least one dose.
Most Etihad pilots and cabin crew have received both doses, she said without disclosing precise numbers.
The airline has been offering staff a vaccine developed by China s Sinopharm, which is also available to the general public in the United Arab Emirates.
The airline has been offering staff a vaccine developed by China s Sinopharm, which is also available to the general public in the UAE.The airline says more than 75% of staff, including Chief Executive Tony Douglas, have received at least the first dose of the vaccine